149 related articles for article (PubMed ID: 8708552)
1. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-restricted T cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: lack of reactivity to glutamic acid decarboxylase.
Huang GC; Tremble J; Bailyes E; Arden SD; Kaye T; McGregor AM; Banga JP
Clin Exp Immunol; 1995 Oct; 102(1):152-8. PubMed ID: 7554382
[TBL] [Abstract][Full Text] [Related]
3. T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes.
Monetini L; Cavallo MG; Barone F; Valente L; Russo M; Walker B; Thorpe R; Pozzilli P
Autoimmunity; 1999; 29(3):171-7. PubMed ID: 10433097
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic islet A2B5- and 3G5-reactive gangliosides are markers of differentiation in rat insulinoma cells.
Bartholomeusz RK; Campbell IL; Harrison LC
Endocrinology; 1989 Jun; 124(6):2680-5. PubMed ID: 2541995
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
7. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
[TBL] [Abstract][Full Text] [Related]
9. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
[TBL] [Abstract][Full Text] [Related]
10. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
Lander T; Nerl C; Held M; Standl E; Mehnert H
Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
[TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic islet cell gangliosides in a solid phase radioassay.
Powers AC; Rabizadeh A; Akeson R; Eisenbarth GS
Endocrinology; 1984 Apr; 114(4):1338-43. PubMed ID: 6368201
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
Gillard BK; Thomas JW; Nell LJ; Marcus DM
J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
[TBL] [Abstract][Full Text] [Related]
14. A2B5-reactive ganglioside expression is an index of differentiation in rat insulinoma (RIN) cells.
Bartholomeusz RK; Campbell IL; Harrison LC
Endocrinology; 1990 Apr; 126(4):1927-33. PubMed ID: 2156672
[TBL] [Abstract][Full Text] [Related]
15. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
Hallberg A; Juhlin C; Berne C; Kämpe O; Karlsson FA
J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of islet cell autoantibodies in terms of insulin release from rat islets and insulinoma cells.
Ejiri K; Taniguchi H; Morimoto Y; Yamashiro Y; Baba S; Srikanta S; Eisenbarth GS
Diabetes Res Clin Pract; 1990 Apr; 9(1):1-5. PubMed ID: 2161728
[TBL] [Abstract][Full Text] [Related]
18. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
19. Serum reactivity against RINm5F purified membrane antigens (ICMA) in newly diagnosed diabetic subjects.
Giordano C; Sapienza N; Mattina A; Pugliese A; Galluzzo A
Diabetes Res; 1990 Nov; 15(3):113-6. PubMed ID: 2132203
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
